TherapeuticsMD, Inc. Has IND Filing Accepted by FDA

The FDA accepted TherapeuticsMD Investigational New Drug application and now the Company can proceed with Phase III clinical trials for its product TX12002HR for hormone therapy.

(PRWeb August 07, 2012)

Read the full story at

Comments are closed.

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.